An expansive biomarker study confirmed OV329 delivered statistically significant inhibition of GABA-AT as measured across ...
Ovid Therapeutics jumps 39% in a month after phase I epilepsy study data show superior efficacy of its lead candidate, OV329, hinting at best-in-class potential.
In Dan Brown's latest novel, lower levels of GABA are the key to expanding our consciousness. But are they really?
A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with ...
Cells called astrocytes are about as abundant in the brain as neurons and new research shows how they are involved in ...
OVID reported positive phase 1 results for OV329, a next-generation GABA-AT inhibitor targeting drug-resistant focal onset ...
Scientists found stranded dolphins show brain changes and toxins linked to Alzheimer’s during harmful algal blooms.
A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with multiple sclerosis also suffer from seizures — a debilitating complication that ...
Less stress and better sleep? One brain-boosting supplement promises to deliver all that and more in pill form.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback